Resectable Skin Squamous Cell Carcinoma
2 clinical trials · Condition
◉ Watch Resectable Skin Squamous Cell Carcinoma
| Record | Firm | Date |
|---|---|---|
| Radiotherapy in Combination With Atezolizumab in Locally Advanced Borderline Resectable or Unresectable Cutaneous SCC (NCT05085496) | City of Hope Medical Center | 2022-04-19 |
| A PD-1 Checkpoint Inhibitor (Cemiplimab) for High-Risk Localized, Locally Recurrent, or Regionally Advanced Skin Cancer (NCT04315701) | University of Southern California | 2020-06-17 |
Track Resectable Skin Squamous Cell Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.